コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 ylamino-4(3H)-pyrimidinone 5'-monophosphate (FAPy).
2 ibosylamino-4(3H)-pyrimidinone 5'-phosphate (FAPy).
3 mino-4-hydroxy-5N-methylformamidopyrimidine (FaPy-7-MeGua), and abasic sites but not DNA substrates c
4 in duplex DNA the AFB moiety of the AFB-beta-FAPY adduct also intercalates on the 5' side of the pyri
6 acking interactions induced by the AFB-alpha-FAPY adduct explain its lower stability as compared to t
10 calation of the AFB moiety for the AFB-alpha-FAPY adduct in the tetramer 5'-d(C(1)T(2)X(3)A(4))-3', i
12 ken together, these characteristics make the FAPY adduct the prime candidate for both the genotoxicit
13 ide moiety is also observed for the AFB-beta-FAPY adduct, and suggests that the identity of the 3'-ne
16 rolyzes to form the formamidopyrimidine (AFB-FAPY) adduct, which interconverts between alpha and beta
19 imidazole ring opening [formamidopyrimidine (Fapy)] and is associated with significant myelosuppressi
20 ibosylamino-4(3H)-pyrimidinone 5'-phosphate (FAPy), as shown by UV-visible spectrophotometry, mass sp
22 Acid hydrolysis of the FAPY adduct gives the FAPY base which exists in two separable but interconvert
24 dibutyrates now establish that the separable FAPY bases and nucleosides are diastereomeric N5 formyl
25 involving the R(a) axial conformation of the FAPY C5-N(5) bond and the E conformation of the formamid
27 idopyrimidine nucleoside repair by examining Fapy*dA and Fapy*dG excision opposite all four native 2'
29 tected from formamidopyrimidine nucleosides (Fapy*dA, Fapy*dG) via a pathway distinct from the Escher
30 st chemical syntheses of a monomeric form of Fapy-dA (1) and oligonucleotides containing this lesion
35 The rate constants for deglycosylation of Fapy-dA in the monomeric and oligonucleotide substrates
37 containing the beta-C-nucleoside analogue of Fapy.dA (beta-C-Fapy.dA) opposite all native nucleotides
39 ding lesions derived from 2'-deoxyadenosine, Fapy.dA and 8-oxo-dA, were not detectably mutagenic in t
42 hibitor (K(I) = 3.5 +/- 0.3 nM) of repair of Fapy.dA by Fpg, suggesting the C-nucleoside may have use
48 ng formamidopyrimidine lesions indicate that Fapy.dA is readily identified as an alkali-labile lesion
50 ple turnovers are observed for the repair of Fapy.dA mispairs in a short period of time, indicating t
53 rachromosomal probes containing a Fapy.dG or Fapy.dA site-specifically incorporated, which showed une
54 IV incision of the C-nucleoside analogues of Fapy.dA was used to establish selectivity for the alpha-
55 e diastereomers of C-nucleoside analogues of Fapy.dA were introduced by using the respective phosphor
57 eta-C-nucleoside analogue of Fapy.dA (beta-C-Fapy.dA) opposite all native nucleotides (K(D) < 27 nM),
60 a duplex containing this nucleotide opposite Fapy.dA, nor does it exhibit an increased level of bindi
68 s facile epimerization, but prior works with Fapy*dG analogues have precluded determining its effect
69 anscriptional bypass mutation frequencies of Fapy*dG and 8-OxodGuo measured in RNA products are compa
71 ng the incorporation of nucleotides opposite Fapy*dG and potentially the repair of this structurally
75 Primer-dependent transcriptional bypass of Fapy*dG by T7 RNAP is hindered compared to 2'-deoxyguano
77 e nucleoside repair by examining Fapy*dA and Fapy*dG excision opposite all four native 2'-deoxyribonu
79 crystallographic characterization of natural Fapy*dG in duplex DNA and as the template base for DNA p
84 these data indicate that mutagenic bypass of Fapy*dG is likely to be the source of the mutagenic effe
95 mentary kinetic studies have determined that Fapy*dG promotes mutagenesis by decreasing the catalytic
100 ,6-diamino-4-hydroxy-5-formamido-pyrimidine (Fapy*dG) is formed from a common intermediate and in com
101 om formamidopyrimidine nucleosides (Fapy*dA, Fapy*dG) via a pathway distinct from the Escherichia col
103 ide soaking experiments trap the ring-opened Fapy*dG, demonstrating that ring opening and epimerizati
104 mammalian polymerase, bypasses a templating Fapy*dG, inserts Fapy*dGTP, and extends from Fapy*dG at
111 d adenosine incorporation, particularly from Fapy*dG:dC bypass which yielded ~25% adenosine incorpora
112 (pol zeta) to incorporate an A opposite AFB1-Fapy-dG and extend from this mismatch, biological eviden
113 godeoxynucleotide d(GCGTACXCATGCG) harboring Fapy-dG as the central residue and developing a protocol
116 of the rate constant for deglycosylation of Fapy-dG in an oligonucleotide, revealed that this lesion
120 Following deprotection and isolation, the Fapy-dG lesion is generated by catalytic hydrogenation a
121 el synthetic strategy to incorporate cognate Fapy-dG site-specifically within any oligodeoxynucleotid
123 2,6-diamino-4-hydroxy-5-formamidopyrimidine (Fapy-dG), could be useful in treating certain cancers.
124 -diamino-4-hydroxy-5-formyl amidopyrimidine (Fapy-dG), is associated with progression of age-related
128 uld catalyze high-fidelity synthesis past NM-Fapy-dG, but only on a template subpopulation, presumabl
129 To elucidate the mechanisms of bypass of NM-Fapy-dG, we performed replication assays in vitro with a
131 tary d(CGCATGCGTACGC) counterpart yields two Fapy-dG.C duplexes that are differentially destabilized
136 a low dA misincorporation frequency opposite Fapy.dG and inefficient extension of a Fapy.dG:dA base p
141 ee versus error-prone incorporation opposite Fapy.dG are significantly reduced in comparison with und
145 , polymerase-mediated introduction of beta-C-Fapy.dG could be useful for incorporating useful amounts
147 e alpha- and beta-configurational isomers of Fapy.dG have distinct effects on Pol II insertion and ex
156 r in simian kidney (COS-7) cells showed that Fapy.dG is mutagenic inducing primarily targeted Fapy.G-
159 istic framework for better understanding how Fapy.dG lesions impact transcription and subsequent path
161 incorporation could account for the level of Fapy.dG observed in cells if 1% of the dGTP pool is conv
164 kinetic studies to investigate the impact of Fapy.dG on three key transcriptional fidelity checkpoint
165 n using extrachromosomal probes containing a Fapy.dG or Fapy.dA site-specifically incorporated, which
168 different structures were solved, including Fapy.dG template-loading state (apo), error-free cytidin
170 for synthesizing oligonucleotides containing Fapy.dG utilized a reverse dinucleotide phosphoramidite,
171 the 5'-TGT sequence mutational frequency of Fapy.dG was approximately 30%, whereas in the 5'-TGA seq
173 anosine (8-OxodGuo) and formamidopyrimidine (Fapy.dG), are produced from a common chemical intermedia
174 uctural basis of transcription processing of Fapy.dG, five different structures were solved, includin
175 was found to be slightly less mutagenic than Fapy.dG, though it also exhibited a similar context effe
176 for synthesizing oligonucleotides containing Fapy.dG, which does not require reverse phosphoramidites
180 ind duplexes containing Fapy.dG.dC or beta-C-Fapy.dG.dC compared to those in which the lesion is oppo
181 Fpg also prefers to bind duplexes containing Fapy.dG.dC or beta-C-Fapy.dG.dC compared to those in whi
183 oduct state (postchemistry), and error-prone Fapy.dG:A product state (postchemistry), revealing disti
185 ATP binding state (prechemistry), error-free Fapy.dG:C product state (postchemistry), and error-prone
186 osite Fapy.dG and inefficient extension of a Fapy.dG:dA base pair work synergistically to minimize th
187 tal structures of a configurationally stable Fapy*dGTP analog, beta-C-Fapy*dGTP, with DNA polymerase
188 herefore, under oxidative stress conditions, Fapy*dGTP could become a pro-mutagenic substrate for ins
189 kinetic data indicate that binding of beta-C-Fapy*dGTP impedes enzyme closure, thus hindering inserti
192 ctive site residue, Asp276, positions beta-C-Fapy*dGTP so that it distorts the geometry of critical c
193 rase, bypasses a templating Fapy*dG, inserts Fapy*dGTP, and extends from Fapy*dG at the primer termin
194 y*dG is in its nucleotide triphosphate form, Fapy*dGTP, it is inefficiently cleansed from the nucleot
197 polymerase I from Escherichia coli accepted Fapy.dGTP and beta-C-Fapy.dGTP as substrates much less e
198 ses is enhanced by inefficient hydrolysis of Fapy.dGTP and beta-C-Fapy.dGTP by MutT, the E. coli enzy
199 cherichia coli accepted Fapy.dGTP and beta-C-Fapy.dGTP as substrates much less efficiently than it di
200 efficient hydrolysis of Fapy.dGTP and beta-C-Fapy.dGTP by MutT, the E. coli enzyme that releases pyro
201 ,6-diamino-4-hydroxy-5-f ormamidopyrimidine (Fapy.dGTP) and its C-nucleoside analogue (beta-C-Fapy.dG
204 n 3-methyladenine DNA glycosylases I and II, FAPY DNA glycosylase, both known apurinic/apyrimidinic e
208 ed unequivocally that in simian kidney cells Fapy.G-->T substitutions occur at a higher frequency tha
211 the 5'-TGA sequence, while stacking for anti-Fapy.G:dCTP pairs was similar in the two sequences.
213 ibosylamino-4(3H)-pyrimidinone 5'-phosphate (FAPy), has been shown to require Mg2+ for catalytic acti
214 Gua, and (ii) one proposed rotamer of AFB(1)-FAPY is a block to replication, even when the efficient
217 ucts allowed us to investigate the repair of Fapy lesions in nuclear and mitochondrial extracts from
219 or exacerbating the mutagenic properties of Fapy lesions, their excision by three glycosylases, Fpg,
220 putatively nonmutagenic formamidopyrimidine (Fapy) lesions of adenine (Ade) and guanine (Gua) to eluc
223 n became important when one of the two major FAPY species in DNA was found to be potently mutagenic a
224 In oligodeoxynucleotides, two equilibrating FAPY species, separable by HPLC, are assigned as anomers
225 C(16)A(17)T(18)A(19)G(20))-3' (X = AFB-alpha-FAPY) using molecular dynamics calculations restrained b
226 ng properties of this DNA adduct: (i) AFB(1)-FAPY was found to cause a G to T mutation frequency in E